The agreement provides MD International with the right to sell in Latin America and includes minimum purchase requirements. To date, four SonaStar systems have been shipped to Chile through MD International prior to executing this agreement.
According to the company, the SonaStar system allows physicians to perform the delicate, selective removal of tumors or other abnormal tissue while sparing vessels as much as possible. In addition, the system is capable of performing precise bone shaving (shaping) and is compatible with most electrocautery devices – controlling bleeding during certain surgical procedures.
BoneScalpel is a new ultrasonic osteotome (or bone cutting device) for use in orthopedic and neurological applications related to the spine and cranium.
Michael McManus, Jr, president and CEO of Misonix, said: “Our relationship is off to a solid start with the shipment of four Sonastar systems prior to this agreement and we believe this agreement is a strong step forward in our strategy to achieve greater market recognition of our advanced medical device products throughout the region.”